STOCK TITAN

KORU Medical Systems Inc - KRMD STOCK NEWS

Welcome to our dedicated news page for KORU Medical Systems (Ticker: KRMD), a resource for investors and traders seeking the latest updates and insights on KORU Medical Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KORU Medical Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KORU Medical Systems's position in the market.

Rhea-AI Summary
KORU Medical Systems (KRMD) will report its first quarter 2024 financial results on May 1, 2024. The company focuses on developing, manufacturing, and commercializing large volume subcutaneous infusion solutions. A conference call and webcast will be held to discuss the financial results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.4%
Tags
conferences earnings
-
Rhea-AI Summary
KORU Medical Systems, Inc. (KRMD) successfully appealed an audit report by The British Standards Institute (BSI) in the EU, ensuring no interruption in product sales. The company's certification remains intact, allowing for continued expansion in the international market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.73%
Tags
none
-
Rhea-AI Summary
KORU Medical Systems, Inc. announces data on the impact of the Freedom Infusion System on subcutaneous immunoglobulin therapy for primary immunodeficiency diseases. The study analyzed data from 3,787 US PIDD patients using KORU Medical infusion systems, showing a 97% adherence rate. The abstract will be presented at the NHIA 2024 Conference by Brent Rutland, VP of Medical Affairs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
conferences
Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) reported financial results for Q4 and full year 2023, with 2% decrease in Q4 net revenues and 2% increase in full year net revenues. The company achieved 6.7% core business growth, improved gross margins, and positive cash flow. They entered collaborations for Novel Therapies and issued guidance for 2024 with expected revenue growth of 10-13%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.3%
Tags
-
Rhea-AI Summary
KORU Medical Systems, Inc. (KRMD) collaborates with a global pharmaceutical manufacturer for a feasibility study on its Freedom Infusion System for a rare disease therapy. The Company aims to develop a customized system for subcutaneous administration in ambulatory infusion centers and hospitals. CEO Linda Tharby expresses excitement for expanding into new therapeutic settings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
KORU Medical Systems, Inc. (KRMD) announces a clinical supply agreement for a novel subcutaneous immunoglobulin drug entering Phase 3 trials. The custom product developed aims to treat autoimmune diseases, primary immunodeficiency disorders, and neurological disorders. KORU Medical's advanced device enhances patient comfort and therapy delivery, showcasing their commitment to healthcare innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.39%
Tags
Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will report Q4 and full year 2023 financial results on March 13, 2024. The company focuses on subcutaneous infusion solutions. A conference call and webcast will be held to discuss the results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
conferences earnings
-
Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023. The management will present at 1:30 pm ET. Interested parties can access the webcast on the News/Events page of KORU Medical’s website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
conferences
-
Rhea-AI Summary
KORU Medical Systems, Inc. (KRMD) to host investor day at headquarters, featuring presentations on key markets, growth strategy, product portfolio, and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
conferences
Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) announces a development agreement with a biopharmaceutical manufacturer to create a next-generation infusion system for subcutaneous immunoglobulin (SCIg) therapy, aiming to improve patient experience and facilitate easier home therapy. The collaboration reflects KORU Medical's commitment to providing innovative specialty subcutaneous infusion solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
none
KORU Medical Systems Inc

Nasdaq:KRMD

KRMD Rankings

KRMD Stock Data

96.87M
31.97M
6.37%
57.59%
2.26%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Mahwah

About KRMD

repro medsystems inc is a company based out of 24 carpenter road, chester, new york, united states.